Comparison of clinical characteristics of acute myocardial infarction in aborigines and nonaborigines in Taitung area of Taiwan

Angiology

Volumn 58, Issue 1, 2007, Pages 61-66

  Wang, Kuang Te ^a   Chen, Chun Yen ^a   Hou, Charles Jia Yin ^a   Tsai, Cheng Ho ^a   Yeh, Hung I ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; URIC ACID;

ABORIGINE; ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE CLASSIFICATION; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE REGRESSION; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; TAIWAN; URIC ACID BLOOD LEVEL;

AGE DISTRIBUTION; AGED; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS; ETHNIC GROUPS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SEX DISTRIBUTION; SMOKING; TAIWAN; TRIGLYCERIDES; URIC ACID;

EID: 33847022598     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319706295467     Document Type: Article

References (24)

1. Department of Heath, Executive Yuan, Taiwan, R.O.C.
2. Li YB, Bruce RA, Ting N, et al: Incidence and risk factors of coronary heart disease and cerebral vascular accident in Chinese men: A remarkable low prevalence of risk factors for coronary heart disease. Chin J Cardiol 1: 143-155, 1981.
3. Tseng C-H: Body composition as a risk factor for coronary artery disease in Chinese type 2 diabetic patients in Taiwan. Circ J 67: 479-484, 2003.
4. Ding YA, Chen D, Li YB: Lipid abnormalities of atherosclerotic disease in Chinese men. J Formos Med Assoc 81: 559-567, 1982.
5. Lee M-L, Lai C-P, Chao Y-F: Risk factor of coronary artery disease in eastern Taiwan. Tzu Chi Med J 7: 285-291, 1995.
6. Chou CT, Lai JS: The epidemiology of hyperuricaemia and gout in Taiwan aborigines. Br J Rheumatol 37: 258-262, 1998.
7. Chien K-L, Lee W-C, Sung F-C, et al: Sex difference in the mortality trends of acute myocardial infarction in Taiwan, 1974 to 1993. J Formos Med Assoc 97: 309-314, 1998.
8. Hsu Y-C, Cheng J-J, Lee S-H, et al: The causes and clinical outcomes in acute myocardial infarction patients without primary PTCA. J Emerg Crit Care Med 11: 10-15, 2000.
9. Martin MJ, Browner WS, Hulley SB: Serum cholesterol, blood pressure, and mortality [Letter]. Lancet 1: 503-503, 1987.
10. Jousilahti P, Vartiainen E, Pekkanen J, et al: Serum cholesterol distribution and coronary heart disease risk: Observations and predictions among middle-aged population in eastern Finland. Circulation 97: 1087-1094, 1998.
11. Marcus FI, Friday K, McCans J, et al: Age-related prognosis after acute myocardial infarction (the multicenter Diltiazem postinfarction trial). Am J Cardiol 65: 559-566, 1990.
12. Rich MW, Bosner MS, Chung MK, et al: Is age an independent predictor of early and late mortality in patients with acute myocardial infarction ? Am J Med 92: 7-13, 1992.
13. Goldberg RJ, McCormick D, Gurwitz JH, et al: Age-related trends in short- and long-term survival after acute myocardial infarction: A 20-year population-based perspective (1975-1995). Am J Cardiol 82: 1311-1317, 1998.
14. Miller TD, Christian TF, Hodge DO, et al: Comparison of acute myocardial infarct size to two-year mortality in patients <65 to those > or = 65 years of age. Am J Cardiol 84: 1170-1175, 1999.
15. Moriarity JT, Folsom AR, Iribarren C, et al: Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 10: 136-143, 2000.
16. Wannamethee SG, Shaper AG, Whincup PH: Serum urate and the risk of major coronary heart disease events. Heart 78: 147-153, 1997.
17. Culleton BF, Larson MG, Kannel WB, et al: Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 131: 7-13, 1999.
18. Freedman DS, Williamson DF, Gunter EW, et al: Relation of serum uric acid to mortality and ischemic heart disease: The NHANES I epidemiologic follow-up study. Am J Epidemiol 141: 637-644, 1995.
19. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283: 2404-2410, 2000.
20. Sica DA: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Curr Hypertens Rep 4: 321-323, 2002.
21. Hwang C-T, Tsai C-H, Feng C-K, et al: The related factors of serum uric acid concentration in helping aboriginal elderly. Public Health (Taiwan) 27: 277-285, 2001.
22. Chang FT, Chang SJ, Wu YY, et al: Body mass index and hyperuricemia differences between aboriginal and non-aboriginal children in Taiwan. Gaoxiong Yi Xue Ke Xue Za Zhi 1: 315-321, 1995.
23. Chang HY, Pan WH, Yeh WT, et al: Hyperuricemia and gout in Taiwan: Results from the Nutritional and Health Survey in Taiwan (1993-1996). J Rheumatol 8: 1640-1646, 2001.
24. Ko YC, Wang TN, Tsai LY, et al: High prevalence of hyperuricemia in adolescent Taiwan aborigines. J Rheumatol 9: 837-842, 2002.